Net Income

Hippo's tech-driven home insurance is now on Progressive's platform in 8 states, a strategic play for scale and improved financial performance.

Creative Homes breaks ground on a luxury home in Lake Elmo, with all proceeds funding St. Jude's fight against childhood cancer. A house built on hope.

A leading firearms maker partners with the National Forest Foundation, linking special edition rifle sales to reforestation and wildlife restoration projects.

Annovis Bio's new trial for buntanetap uses an AI-powered Apple Watch app to track symptoms, aiming for more precise data in the race for a cure.

With a new CEO driven by a personal mission, Cylinder Health aims to scale its virtual care model in the booming, high-cost digestive health market.

Sylogist reports strong SaaS revenue growth but an overall revenue decline and net loss, highlighting the high stakes of its ongoing business transformation.

A novel blood test from C2N Diagnostics, used in a major Alzheimer's trial, shows promise in predicting disease progression, heralding a new era of precision medicine.

The Ontario Real Estate Association is calling for a radical overhaul of development charges to tackle housing affordability. Will it work?

The toy giant's 600,000-square-foot facility is more than a warehouse; it's a key move in its plan for faster delivery and supply chain dominance.

A new biotech spins out with a novel drug class aiming to provide healthier, more durable weight loss and combat cancer-related wasting syndrome.

A new drug shows unprecedented activity against all common cold viruses, a major breakthrough for millions suffering from chronic lung diseases.

The equipment dealer exceeded its inventory reduction goals but faces a net loss and a grim forecast amid a broader agricultural market slump.

As its new obesity drug enters a key trial, Biohaven bets on a novel approach: reducing fat while preserving precious muscle mass. Can it redefine weight loss?

Net Lease Office Properties rewards shareholders with a $3.30 special dividend, funded by property sales, amid a challenging office real estate market.

Belief BioMed's single-dose treatment for hemophilia B, BBM-H901, is now approved in Macao, offering a new horizon for patients beyond frequent injections.

Despite new regulations, LexinFintech's 2025 net profit surged 52.4%. See how risk management and a booming e-commerce arm fueled its resilience.

Silicom is set to meet investors, highlighting a return to growth and its expanding AI-inference solutions. Is this the start of a major turnaround?

As costs soar, Angle Health's new webinar series brings in top experts to offer brokers and employers actionable strategies on everything from pharmacy spend to AI.

Centre for Neuro Skills appoints Jay Varma to lead a new employer partnership strategy, signaling a major shift in managing workforce neurological health.

Woodrow AI has launched a specialized agent for finance teams, promising the accuracy and audit trails that have kept AI out of the back office until now.